GLOBUS MEDICAL INCORPORATED (GMED)

(NYSE:GMED) is one of the cheap robotics stocks to buy right now. On May 18, Citizens reiterated a Market Perform rating on Globus Medical (NYSE:GMED) on first-quarter results exceeding expectations. The impressive results were characterized by 27% overall revenue growth and record earnings.

Globus Medical Inc. (NYSE:GMED) is one of the most profitable growth stocks to buy. On May 7, Globus Medical reported a strong start to 2026, with worldwide net sales reaching $759.9 million for Q1, representing a 27.0% increase. The company’s core spine business and enabling technologies ...

Globus Medical is riding on musculoskeletal market growth with strong Q1 sales gains, double-digit spine growth, and rising trauma demand across key product lines.

Over the past six months, Globus Medical’s shares (currently trading at $79.99) have posted a disappointing 10.1% loss, well below the S&P 500’s 10.7% gain. ...

GuruAI Model Portfolios All-In-One ... Calendar Earnings Calendar & Reports Analyst Ratings Embed Widgets Stock Market Holidays Transcripts Search Peter Lynch Chart ... Chat Support Create a ticket User Engagement Meeting 469-248-6885 Status Take Survey Give us your feedback ... On June 09, 2026, Gl…